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The importance of a multi-disciplinary team (MDT) approach to conventional surgical techniques has strong 
empirical support. The MDT approach to robotic-assisted surgery (RAS) has not been clearly defined, 
which encourages prospectively poor MDT performance. Poor performance of the MDT approach, allied 
to the constant evolution of technology-assisted surgery, can generate unacceptable operative and patient 
outcomes. This review offers a nursing perspective to the complex paradigm of thoracic RAS, demonstrating 
key indicators to perioperative MDT engagement. This will be achieved by offering a rationale for RAS 
in pulmonary resection, identifying additional surgeries where utility is demonstrated. Evaluation of 
the available evidence will synthesize clinical quality indicators, while key strategies in effective MDT 
development can be summarised. Conclusively, bespoke and experiential knowledge will be shared, based 
upon the investigatory findings discussed throughout this article. Allied to a recommended developmental 
framework, this perspective should allow for transfer of knowledge, creation and replication of useful 
interventions. Lung cancer is an ever-increasing global concern, currently being the co-modal cancer with an 
estimated 2.09 million cases worldwide. Populations are ageing and with annual global costs of at least $1.16 
trillion, effective treatments are required. RAS shows promise in treating large and complex lesions when 
compared to a video-assisted thoracoscopic surgery (VATS) approach. A critical indicator being enhanced 
vision and dexterity in comparison to a VATS approach. Economically, RAS has proven to be an expensive 
technique, however, when initial purchase costs are excluded, intra-operatively, there are ways to narrow the 
expense gap and make RAS cheaper. When assessing per hospital stay, exclusive of initial purchase cost, RAS 
is found to be cheaper than open thoracotomy. This article demonstrates that RAS for pulmonary resection 
has utility for complex lesions where a VATS approach would be unsuitable. Crucially, as with all complex 
surgery, the MDT must be performed effectively for optimum patient outcomes.
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Perspective
Introduction
The World Health Organisation (1) has identified lung 
cancer as the co-modal cancer worldwide, alongside breast 
cancer. There are currently 2.09 million reported cases of 
lung cancer worldwide, which led to 1.76 million deaths 
over a one-year period, with an estimated 80% of these 
cancers caused through tobacco smoking or exposure (1).
Seminally, Doll & Hill (2) identified a link between 
smoking and lung carcinoma, however, noted 31.7% of 
their sample were non-smokers with lung carcinoma. Cufari 
et al. (3) more recently discussed a trend in ‘never-smokers’ 
with lung cancer, identifying a 15% increase in lung cancer 
rates of non-smokers between 2008 and 2014. Interestingly, 
Cufari et al. (3) concluded there is little evidence to attribute 
the rise to any single cause. Tomasetti & Vogelstein (4) 
tentatively suggest ‘replicative mutations’ in stem cell 
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division could be a relatively unexplored causation in cancer, 
with the risk of development increasing with age.
Prospectively, the Global Burden of Disease Cancer 
Collaboration (5) note a 29% rise in tracheal, bronchus and 
lung (TBL) cancers since 2005; 18% attributable to ageing 
population and 12% to population growth. In the UK, 
the Government Office for Science (6) suggest a national 
population growth of 9.7 million people from 2014 to 2039 
(from 64.6 to 74.3 million). The highest percentage growth 
will be in the over 60 age group, prospectively increasing 
from 14.9 to 21.9 million. This indicates over 70% of the 
population increase will be in the over 60 age group. This 
may potentially increase the number of cancer diagnoses 
due to replicative mutation.
When assessing the costs of cancer globally, the 2010 
figure was $1.16 trillion (7). This will have elevated when 
allied with an increase in the ageing population (6). Lifestyle 
risk factors in cancer have increased in propensity and 
are identified as: increased alcohol intake, unhealthy diet 
and physical inactivity (1). Screening and early diagnosis 
are key in reducing the burden of cancer on a healthcare 
organisation; while adequate pathology systems will 
improve the chances of good outcomes (1). Effective cancer 
screening, early diagnosis and pathological sampling will 
often lead to surgery, requiring a highly specialised multi-
disciplinary team (MDT).
A growth area within UK health and social care is 
assistive health technology, and due to the rapid evolution 
of this sector, it is difficult to accurately judge the scale 
of their impact (6). One assistive technology currently 
used in global healthcare is the Intuitive Surgical DaVinci 
robotic system, in Si and concurrently Xi and X platforms 
(Intuitive Surgical Inc.). Robotic-assisted surgery (RAS) for 
pulmonary resection has been described in literature since 
the early 2000’s. RAS is shown to have utility for anterior 
mediastinal surgery (Myasthenia Gravis and Thymectomy), 
posterior mediastinal tumours (neurogenic tumours, 
lymphatic system tumours and oesophageal cyst removal), 
oesophageal resection and Heller’s Myotomy (8).
Evidence in thoracic RAS
The most common surgical robotic system is the Intuitive 
Surgical Inc., DaVinci system. This comes in Si and 
concurrently Xi and X forms (Intuitive Surgical Inc.) (9). 
This system offers provision for a maximum of 4 robotic 
arms to be operated remotely by an adequately trained 
surgeon (3 mm × 8 mm instrumentation arms and 1 mm × 
12 mm camera arm).
Seminally, Melfi et al. (10) described their early 
experience of RAS in pulmonary resection. Five patients 
underwent RAS, with all 5 having peripheral opacities 
(three stage 1 bronchogenic carcinoma and two typical 
carcinoid lesions). Of the 5 patients, 2 were converted 
to mini-thoracotomy with no technical mishap cited. It 
was concluded that RAS pulmonary resection is possible, 
however, they noted that considerable improvements were 
needed for safe and expeditiously performed pulmonary 
lobectomy.
Louie et al. (11) illustrated their comparative early 
experience of 40 RAS lobectomies versus 35 mature 
technique video-assisted thoracoscopic surgery (VATS) 
lobectomies. They illustrated their results of RAS versus 
VATS as follows: Mean operative time (213 versus 
208 minutes), blood loss (153 versus 134 mL), intensive 
care stay (0.9 versus 0.6 days) and length of stay (4.0 versus 
4.5 days). They indicated similar results between techniques, 
concluding RAS to be at no technical disadvantage. 
Expanding sample sizes, Dylewski et al. [2011] identified 
200 consecutive RAS pulmonary resection cases (stating 
154 lobectomy, 4 bilobectomy, 35 segmentectomy, 3 sleeve 
lobectomy, 3 en bloc resection and 1 pneumonectomy). 
Median values were: 90-minute operating time, 70 mL 
intraoperative blood loss and 3-day hospital stay. Sixty-
day mortality and morbidity rates were 2% and 26% 
respectively, with the largest lesion at 8.5 cm. VATS 
limitations are cited as counterintuitive orientation, 
2-dimensional imaging, reduced depth perception and 
limited instrument manoeuvrability. RAS is suggested to be 
technically superior in these areas. 
Dylewski et al. (12) identified patient selection criteria 
for RAS as adequate cardiopulmonary reserve, peripherally 
located lesion(s) and pathologically proven non-small cell 
lung carcinoma (NSCLC), no clinical or pathological 
evidence of mediastinal nodal involvement and no lesion 
located in close proximity to hilar structures. Cerfolio 
et al. [2011a] supportively identified NSCLC, adequate 
cardiopulmonary reserve and mediastinal lymph node 
negative as RAS selection criteria, and additionally, 
advocated for pre-operative computerised tomography 
(CT) scan, positron emission tomography (PET), stress 
test and pulmonary function (within normal reference 
ranges). Interestingly, Cerfolio et al. [2011b] stipulated RAS 
exclusion criteria as segmental bronchus or more proximal 
tumour location, chest wall involvement requiring rib 
resection, N2 node positive and patient refusal of RAS.
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When consent is received for RAS, both Dylewski 
et al. (12) and Cerfolio et al. (13) conclude that potentially 
superior lymphadenectomy is possible over VATS and open 
surgery. Cerfolio et al. (13) identified a consecutive sample 
of 150 patients, concluding all cancer patients received a 
margin negative (R0) resection and all visible N1 and N2 
lymph nodes can be completely extirpated, citing a median 
of 14 lymph nodes removed for NSCLC. 
Cerfolio et al. (14) identified a consecutive patient 
sample of 168, with 148 undergoing RAS surgery (7 with 
metastatic pleural disease and 13 conversions, with 2 due 
to intraoperative bleeding). All cancer patients underwent 
R0 resection, with a median of five N2 and three N1 nodal 
stations, concluding RAS technique for pulmonary resection 
is “oncologically sound”. Cerfolio et al. (14) compellingly 
compared RAS pulmonary resection to propensity-matched 
nerve-sparing thoracotomy. One hundred forty eight 
patients underwent RAS (106 lobectomy cases, 26 wedge 
resection and 16 segmentectomy) versus 318 nerve-sparing 
thoracotomy cases. A provocative case was presented for 
VATS being an unsuitable comparison to RAS due to 
limitations in lesion ability in VATS (lesion size <4 cm, 
without N1 disease). The largest RAS resection in this 
study was 9.4 cm, potentially indicating a superior level of 
dexterity in RAS over VATS. 
Cerfolio et al. (14) described clinical results of nerve-
sparing thoracotomy versus RAS are consecutively: 
morbidity 38% versus 27%, mortality 3.1% versus 0%, 
chest drain duration 3.0 days versus 1.5 days, post-operative 
pain score median and range at 3 weeks 4.4 [0–8] versus 2.5 
[0–7] and hospital stay median and range 4.0 [1–67] versus 
2.0 [1–7]. Interestingly, post-operative RAS morbidities 
are identified as transient atrial fibrillation (12 patients), air 
leak (10 patients), chylothorax (2 patients), pneumothorax 
post drain removal (2 patients), subcutaneous emphysema 
(6 patients) and respiratory distress requiring reintubation 
(1 patient).
Cerfolio et al. (13) illustrated a completely portal robotic 
lobectomy with 4-arm (CPRL-4), building upon the 
work on Ninan & Dylewski (15) who described a totally 
portal 3-arm approach without utility thoracotomy as 
technically possible. Cerfolio and colleagues (13) indicated 
the main benefit of CPRL-4 over 3-arm is autonomous 
lung retraction, also streamlining specimen extraction. 
Secondary benefits include 3-dimensional vision to improve 
precision. Crucially, full team training is identified as critical 
to optimise patient safety.
RAS can be an expensive technique. A US study by 
Park & Flores (16) suggests costs up to $3,981 more than 
VATS, however, it can potentially be $3,988 less than open 
thoracotomy. A more contemporary cost-analysis came 
from a sample of 112 patients in France (17), identifying 57 
RAS versus 55 VATS pulmonary resections, with median 
operative costings of €13,424 versus €11,759 respectively. 
Additionally, you must also factor in initial purchase costs. 
In the UK, they are roughly £1.7 million, with maintenance 
costs of an estimated £10,000 per annum (18,19). 
In a large-scale comparative study of 15,502 lung 
resection patients from 305 hospitals (665 underwent 
RAS, 335 lobectomies, 330 wedge resection). Swanson 
et al. (20) identified total hospital costs for RAS and VATS 
lobectomy as $25,040.70 versus $20,476.60 respectively; 
with wedge resection totalling $19,592.40 versus $16,600.10 
respectively. Incidentally, Gondé et al. (17) had found 
similar findings, however, noted the open conversion rate 
of VATS and RAS as 16% and 2% respectively, potentially 
suggesting a more dextrous, therefore safer approach in 
RAS. This is congruent to the suggestion of meticulous and 
relatively haemostatic dissections in RAS (12). 
Barriers to effective RAS and rationale to the 
approach
Jones & Sethia (21) describe an increase in cost, elongated 
training periods and lack of strong contextual evidence 
as barriers to effective thoracic RAS. Antoniou et al. (19) 
additionally identify increased set-up times in RAS 
compared to VATS with difficulty in port docking as a 
clinical concern. RAS patients can experience increased 
anaesthetic times, potentially extending the patient recovery 
period and delaying hospital discharge (22). However, 
effective RAS team identification and engagement with 
shared vision will reduce operative times (23,24).
RAS is criticised for lack of tactility and feedback 
for the surgeon compared to a VATS approach (25). 
Reduced tactility can be offset against increased dexterity, 
restoration of normal hand eye co-ordination and improved 
3-dimensional vision in RAS (12,26). Tentative evidence 
can be found through comparative RAS versus VATS 
conversion to open rates—16% versus 2% (17). Intriguingly, 
Lanfranco et al. (26), implies that RAS is awaiting trust in 
surgical technology to develop—identifying availability 
of ‘telepresence surgery’ as a low uptake approach due to 
potential technological distrust. 
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Contextually, Ara Darzi, the foremost health minister 
in the UK, in his report ‘Saws and Scalpels to Lasers and 
Robots’, spoke favourably of keyhole surgery (27). He 
associated potentially reduced infection rates and reduced 
in-patient duration. He did, however, cite an underuse of 
RAS within the NHS. It was identified that RAS needed 
to prove its credentials against other minimally invasive 
techniques. 
Interestingly, Brooks (28) suggests RAS is confounded 
by continually changing international evidence, promoting 
conceptualisation of bespoke empirical evidence to underpin 
interventions. Due to RAS having less suggested practical 
limitations in comparison to other minimal incision 
approaches (12,14), it can be concluded that continuous 
collection, synthesis and publication of RAS data, specific to 
nation, or even region, could strengthen the contemporary 
evidence base. 
Team strategies to improve effectiveness
Although you must be aware of cost implications and 
empirical evidence for commissioning RAS, initial drivers 
are cited as: passion for innovation, developing potential 
benefits and setting realistic goals or targets (29). Adopting 
these criteria for MDT selection is useful. Additionally, 
informing potential stakeholders of clinical benefits, as per 
prior evidence, will support MDT engagement (30).
Sharing goals will influence collaboration and decision 
making among the RAS MDT, identifying transferrable 
training and adequate skill mix amongst candidates (31). 
Pa r t i cu l a r  a t t en t ion  shou ld  be  pa id  to  cur ren t 
Commissioning Policies Groups (CPGs) (if available) 
and literature review where appropriate to develop MDT 
competencies (32). 
Effective teamwork in an operating theatre will include 
cooperation, leadership, coordination, awareness and 
communication (33). These factors can be reinforced using 
a robust framework. WHO (34) Surgical Safety Checklist 
(SSC) should be used. In a multi-national and economically 
diverse cohort of 3,955 patients, surgical mortality figures 
(within 30 days post-op) reduced from 1.5% to 0.8%, with 
in-hospital complications reducing from 11% to 7% (35). 
Communication among surgeons, anaesthetists and nurses 
allied to the SSC is shown to improve standardisation 
of techniques, reducing risk of infection and avoidable 
complications (36). Hull et al. (37) found higher levels of 
MDT feedback improved technical surgical skills. Effective 
MDT communication will identify substantive deficiencies, 
reduce minor problems, leading to shorter, smoother 
and safer surgery (38). The WHO SSC allows for both 
pre-operative MDT communication and post-operative 
feedback through the debrief, encouraging essential iterative 
development.
Hollnagel et al. (39) offer a succinct recommendation of 
contemporary philosophical culture changes in healthcare. 
Moving from the notion of removing incidents altogether 
or ‘as few things as possible go wrong’ culture to accepting 
human fallibility, advocating an approach ensuring ‘as many 
things as possible go right’—termed a safety-II approach. 
Braithwaite et al. (40) in a systematic review of 63 multi-
national articles concluded a positive workplace culture is 
significantly associated with system-related patient outcomes. 
System-related outcomes in healthcare are identified as: 
morbidity, failure to rescue, readmission rates and crucially, 
patient satisfaction. The importance of non-punitive feedback 
cannot be overstated to ensure safe, effective RAS.
Incident reporting will provide key performance feedback 
for improvements in healthcare (41). In the UK, Sujan 
et al. (42) identifies incident reporting as a key foundation 
of safe care, however, warns number of reported incidents 
will not translate instantaneously to clinical improvements. 
Part of a safety-II approach is learning from experience, 
encouraged through a positive culture (39). Part of learning 
from experience includes the importance of near miss 
reporting, which works informally through the WHO 
SSC. However, this must not be centralized, all clinical 
levels must receive incident feedback to ensure reduction in 
performance variability (42). 
Bespoke and experientially effective 
interventions
The Human Factors in Healthcare document (43) 
advocates the enhancement of clinical performance through 
a development framework based upon teamwork, tasks, 
equipment, workspace, culture and organisation. This is 
applied to RAS below.
Teamwork
 Consistent RAS MDT for identified learning curve to 
improve standardisation of approach;
 Entire RAS team familiar with VATS and open 
thoracotomy;
 Identify nurses with experience in first-assistant role if 
available;
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 Anaesthetist has ready access to airway, including 
transparent drape (Figure 1);
 WHO SSC as feedback framework:
 Team HUG prior to anaesthetic induction (ideally 
around patient CT scan and/or X-ray);
 Set-up time, knife-to-skin, docking, un-docking, skin 
closure times and blood loss recorded;
 Full MDT SSC debrief performed.
Task
 Surgeon to discuss with MDT why RAS approach 
chosen;
 Patient operative positioning is paramount to effective 
RAS, aim for reproducibility (Figure 2);
 Proximity and ability for surgeon to see patient also 
important (Figure 2);
 Pre-decided conversion to open criteria—explicit plan B;
 Rigorous maintenance of binocular vision for surgeon;
 Identify time limit for RAS to avoid prolonged 
anaesthesia/team frustration
 Video recording of cases for review (if possible).
Equipment
 Cost reduction through reduced robotic instrumentation 
(Figure 3). 2× Cadiere Forceps, fenestrated Bipolar 
Forceps and Permanent Cautery Hook;
 Transparent drape for airway monitoring is essential 
(Figure 1);
 Non-linting, 10 cm × 10 cm hydrophilic neurosurgical 
patties advisable (can be dried and re-used in situ to 
reduce CO2 loss);
 Blue coloured silastic vessel loops for contrast against 
background (consistently cut to 10 cm);
 Continuous evaluation of cost, effectiveness and 
alternative equipment;
Workspace
 Identify the largest operating room possible;
 Use the same operating room consistently—identify 
standardised landmarks for standardisation;
 Ensure additional slave monitors for improved MDT 
engagement;
Figure 1 Anesthetist view (right sided surgery).
Figure 2 Surgeon’s eye view.
Figure 3 Reduced robotic instrumentation.
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 Ensure surgeon has accessible view of patient and 
bedside assistant for effective communication (Figure 2).
Culture/organisation
 Engage with safety framework—WHO SSC;
 Debrief as an MDT for innovation (i.e., sub-xiphoid 
approach);
 Report incidents and near miss events;
 Encourage feedback to inform clinical standards;
 Advocate cross fertilisation among specialities;
 Use each case as a group learning exercise.
Conclusions
RAS is an effective approach to pulmonary resection, 
however, without a highly effective MDT, RAS will fail to 
deliver optimal patient benefits. As the co-modal global 
cancer, with over 2 million people currently suffering, 
there is a worldwide demand for highly effective treatment. 
Causation is widely acknowledged, with appropriate 
screening and early diagnosis available among many 
national healthcare systems. Surgery will become an option 
for many of the 2 million plus lung cancer sufferers.
Provocatively, VATS may be an unsuitable comparison 
for RAS due to counterintuitive orientation, 2-dimensional 
vision, reduced depth perception, inferior instrument 
manoeuvrability and utility for larger, more complex lesions 
in RAS.
Empirical evidence suggests RAS resection margins are 
reliable. Lymphadenectomy is suggested to be superior to 
VATS, however, not explicitly discussed in relation to open 
thoracotomy. Conversion rates in RAS (2%) are as less 
than VATS (16%), potentially due to improved dexterity 
and precision. Favourable morbidity and mortality rates 
are disclosed for RAS when compared to both VATS and 
open thoracotomy. Initial purchase costs are high for RAS 
at £1.7 million, with high annual maintenance at £100,000. 
RAS costings are $3–4,500 higher per hospital stay than 
VATS, however, they are thought to be $4,000 less than 
open thoracotomy. 
RAS shows ability in complex thoracic surgery. As with 
any complex surgery, proposed ability is inconsequential 
without a highly performing team. The effectiveness of 
any thoracic RAS programme relies almost entirely on an 
MDT working towards an aspired outcome: shared team 
goals, passionate innovation and critical evaluation—more 
people than ever are relying on us to get it right.
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